Changeflow GovPing Healthcare & Life Sciences Proceade-CRC-03: Two Drug Regimens for Metastat...
Routine Notice Added Final

Proceade-CRC-03: Two Drug Regimens for Metastatic Colorectal Cancer

Email

Summary

ClinicalTrials.gov has registered Proceade-CRC-03 (NCT07549412), a Phase 3 clinical trial evaluating two drug regimens for the treatment of metastatic colorectal cancer. The trial is catalogued under Phase 3 studies sorted by start date. This entry provides standardized trial information for public and researcher access, including study objectives, participant eligibility criteria, and anticipated endpoints.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.

What changed

ClinicalTrials.gov has added a new Phase 3 trial registration for Proceade-CRC-03, designated NCT07549412. The trial studies two drug regimens in patients with metastatic colorectal cancer. Clinical trial registrations on ClinicalTrials.gov provide standardized protocol information including study design, eligibility criteria, locations, and investigators, and do not constitute regulatory approval or endorsement of the investigational treatment. Researchers and patients can reference this record for enrollment eligibility and trial location information.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Clinical investigators Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical trial registration Drug regimen study
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Topics
Healthcare Clinical Operations

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!